期刊文献+

超高效液相色谱法测定癫痫患儿拉考沙胺血药浓度

Determination of Blood Concentration of Lacosamide in Children with Epilepsy by Ultra-High Performance Liquid Chromatography
下载PDF
导出
摘要 目的:建立测定癫痫患儿拉考沙胺(LCM)血药浓度的超高效液相色谱(UPLC)方法。方法:内标为盐酸普萘洛尔;色谱柱为Waters ACQUITY UPLC BEH C_(18)柱(100 mm×2.1 mm,1.7μm);流动相为甲醇-10 mmol/L磷酸二氢铵溶液(45:55,用甲酸调至pH 4.0),流速0.2 mL/min,进样量2μL;检测波长240 nm;柱温30℃。结果:LCM和普萘洛尔的保留时间分别为2.468 min和5.475 min。LCM(X)在1.0~40.0μg/mL浓度范围内与峰面积(Y)的线性关系良好(Y=0.0494X+0.0222,r=0.9998),检测下限为0.50μg/mL(S/N=4),定量下限为1.00μg/mL(S/N=12)。日内精密度1.88%~3.29%,日间精密度2.33%~5.68%,准确度88.75%~105.29%,加样回收率为96.58%~101.76%。LCM血清样品的室温稳定性、长期稳定性和冻融稳定性均较好(偏差<15%)。结论:该方法预前处理简单,分析灵敏度高、特异性强,稳定可靠,能够满足临床LCM治疗药血浓度监测的需求。 Objective:To establish the ultra-high performance liquid chromatography(UPLC)method for determination of blood concentration of lacosamide(LCM)in children with epilepsy.Methods:Phenytoin sodium was used as the internal standard.The Waters ACQUITY UPLC BEH C_(18) column(100 mm×2.1 mm,1.7μm)was used,the mobile phase was methanol-10 mmol/L ammonium dihydrogen phosphate solution(45∶55,adjusted with formic acid to pH 4.0),the flow rate was 0.2 mL/min,the injection volume was 2μL,the detection wavelength was 240 nm,and the column temperature was 30℃.Results:The retention time of LCM and propranolol was 2.468 min and 5.475 min,respectively.LCM(X)showed good linearity with peak area(Y)in the concentration range from 1.0 to 40.0μg/mL(Y=0.049,4X+0.022,2,r=0.999,8),the lower limit of detection was 0.50μg/mL(S/N=4)and the lower limit of quantification was 1.00μg/mL(S/N=12).The intra-day precision was from 1.88%to 3.29%,the inter-day precision was from 2.33%to 5.68%,the accuracy was from 88.75%to 105.29%,and the extraction recovery rate was from 96.58%to 101.76%.The room temperature stability,long-term stability and freeze-thaw stability of LCM samples were good(deviation<15%).Conclusion:The UPLC method has the advantages of simple pre-treatment,high analytical sensitivity,specificity,stability and reliability,and can meet the needs of clinical drug concentration monitoring for LCM treatment.
作者 赵婷 孙岩 冯杰 王婷婷 孙力 李红健 于鲁海 Zhao Ting;Sun Yan;Feng Jie;Wang Tingting;Sun Li;Li Hongjian;Yu Luhai(People’s Hospital of Xinjing Uygur Autonomous Region,Urumqi 830000,China;Children’s Hospital of Xinjing Uygur Autonomous Region,Urumqi 830000,China)
出处 《儿科药学杂志》 CAS 2022年第10期6-10,共5页 Journal of Pediatric Pharmacy
基金 新疆维吾尔自治区人民医院科研基金资助项目,编号20190315。
关键词 超高效液相色谱法 拉考沙胺 血药浓度 ultra-high performance liquid chromatography lacosamide blood concentration
  • 相关文献

参考文献3

二级参考文献32

  • 1司洋(摘译),刘凌,田林郁,慕洁,陈邓,陈涛,邓颖,何君,李尤,何俐,周东.苯巴比妥治疗中国西部农村地区惊厥性癫痫患者的不良反应的初步观察[J].癫痫杂志,2016,2(1):92-92. 被引量:4
  • 2刘娟,高丽.儿童癫认知障碍研究进展[J].实用诊断与治疗杂志,2008,22(1):45-48. 被引量:4
  • 3PATSALOS P N,BERRY D J,BOURGEOIS B F,et al.Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring:a position paper by the subcommission on therapeutic drug monitoring,ILAE Commission on Therapeutic Strategies [J].Epilepsia,2008,49(7);1239-1276.
  • 4PERUCCA E.Clinical pharmacokinetics of new generation antiepileptic drugs at the extremes of age[J].Clin Pharmacokinet,2006,45(4):351-363.
  • 5HADJILOIZOU S M,BOURGEOIS B F.Antiepileptic drug treatment in children[J].Expert Rev Neurother,2007,7(2):179-193.
  • 6ITALIANO D,PERUCCA E.Clinical pharmacokinetics of new- generation antiepileptic drugs at the extremes of age;an update [J].Clin Pharaiacokinet,2013,52(8):627-645.
  • 7WALSON P D.Role of therapeutic drug monitoring(TDM)in pediatric anti-convulsant drug dosing[J].Brain Dev,1994,16(1):23-26.
  • 8SPECHT U,ELSNER H,MAY T W,et al.Postictal serum levels of antiepileptic drugs for detection of noncompliance[J].Epilepsy Behav,2003,4(5):487495.
  • 9MUCKLOW J C,DOLLERY C T.Compliance with anticonvulsant therapy in a hospital clinic and community[J].Br J Glin Pharmacol,1978,6(1):75-79.
  • 10EADIE M J.Indications for plasma drug monitoring in patients with epilepsy.Implications for reducing costs[J].Pharmacoeconomics,1997,11(4):343-349.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部